HOME >> BIOLOGY >> NEWS
New antimicrobial compound adheres to skin to promote healing

Athens, Ga. University Georgia researchers have developed an anti-microbial treatment that adheres to the skin without being toxic.

Already, the treatment has helped heal Spirit, a burned dog in a high-profile animal cruelty case, and Gasper, a beluga whale at the Georgia Aquarium in Atlanta.

The researchers envision a human application for the technology, which they're currently seeking to patent.

Dr. Bran Ritchie, a distinguished research scientist in the department of small animal medicine and surgery at the UGA College of Veterinary Medicine, said the compound, known as Tricide, was initially developed by now retired UGA professor Dr. Richard Wooley to treat burns. It was later applied to skin lesions on fish and other aquatic animals. Tricide works by enhancing the effectiveness of antibiotics.

"In the case of burn victims, whether animal or human, bacteria and fungi can infect the open wounds and kill the patient," Ritchie said. "We have found a way to kill those drug-resistant bacteria and fungi with compounds that cleanse wounds while being gentle on the tissue."

Combining Tricide with a bioadhesive came about as a result of collaboration between Ritchie and Tony Capomacchia, an associate professor in the College of Pharmacy who specializes in the formulation of drug delivery systems.

The first noteworthy application of the Tricide bioadhesive came last year in the treatment of Spirit, the Athens-area dog that was deliberately set on fire. The researchers are currently using the compound to heal skin ulcers on a whale named Gasper who was rescued from a Mexico City amusement park and is now a popular resident of the Georgia Aquarium.

Petroleum-based ointments are commonly used in treating skin infections, but Capomacchia said that petroleum can be toxic and inhibit healing,"Using a petroleum product would be like pouring motor oil into the wound," he said.

Ritchie found that using an oi
'"/>

Contact: Sam Fahmy
sfahmy@uga.edu
706-542-5361
University of Georgia
13-Apr-2006


Page: 1 2

Related biology news :

1. Bacteria recognize antimicrobials, respond with counter-defenses
2. A compound from olive-pomace oil gets 80 percent slowing down of HIV spread
3. New compound effectively treats fungal infections
4. Natural compound and exercise boost memory in mice
5. Lipoic acid explored as anti-aging compound
6. Pharmaceutical compounds found in nations fresh water
7. Chinese medicinal compound stops formation of cysts in polycystic kidney disease in lab
8. EPA selects Phylonix to screen compound library in zebrafish
9. Anti-wrinkle compound causes pathological reaction in skin cells
10. Marine moss reveals clues to anticancer compound
11. New compound prevents alcoholic behavior, relapse in animals by blocking stress response

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
(Date:6/28/2020)... Fla. (PRWEB) , ... June 25, 2020 , ... In ... focus on innovations in accelerated Point of Care Testing solutions (POCT). Check local listings ... Samples are collected at medical offices and are shipped to labs throughout the country. ...
(Date:6/23/2020)... ... 23, 2020 , ... Rigaku Corporation , a global ... a series of TOPIQ webinars, which will cover the Transferable Aspherical Atom Model ... response to social distancing measures that resulted in postponements and cancelations of global ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 17, 2020 , ... ... firm for the life sciences and food industries, is pleased to announce that ... Clinical Research – Business Development. , Charles is an accomplished and results-driven sales ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Technology (MIT) has expanded the company’s exclusive license to include clinical applications ... point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast ...
(Date:7/10/2020)... , ... July 09, 2020 , ... ... cell therapy, today announced the hiring of Allen R. Nissenson, M.D., F.A.C.P., as ... oversee the clinical development of Sentien’s lead product, SBI-101. Dr. Nissenson serves ...
(Date:7/7/2020)... , ... July 06, 2020 , ... ... Awards. Entries from Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts ... Bio-IT World has hosted an elite awards program, highlighting outstanding examples of how ...
Breaking Biology Technology:
Cached News: